Although studies in cancer biology have demonstrated that LOXL2 is able to regulate EMT via stabilisation of the EMT transcription factor Snail9,34, we found no significant reduction in E-Cadherin, which as a primary downstream target of Snail is generally repressed in EMT. The gene discussed is LOXL2; the disease is cancer.